Clinical comparative study assessing the effect of ivabradine on neopterin and NT-Pro BNP against standard treatment in chronic heart failure patients.
Gaidaa M DogheimIbtsam KhairatGamal A OmranSahar M El-HaggarAhmed M El AmrawyRehab H WeridaPublished in: European journal of clinical pharmacology (2022)
Ivabradine therapy reduced levels of both biomarkers which correlated well with HR. Biomarker levels might provide a tool for assessing ivabradine effectiveness in HF. Trial registration Date: June 26, 2020. Identifier: NCT04448899. Link: Ivabradine in Patients with Congestive Heart Failure-Full Text View-ClinicalTrials.gov.